Orotracheal Intubation, Pneumonia
Conditions
Keywords
Orotracheal intubation in emergency, Pneumonia
Brief summary
Orotracheal intubation in emergency medicine is a vital procedure for ensuring adequate oxygenation and ventilation in patients with respiratory distress or in shock. However, this procedure exposes patients to complications such as pneumonia. In the matter of fact, the urgency of the procedure means that it is not possible to wait until the patient's stomach is empty. Pneumonia significantly increase patient morbidity and mortality. Therapeutic management must be early and appropriate to improve the patient's prognosis. The aim of this study is to compare the rate of pneumonia occurring in patients intubated in emergency situations with that in patients intubated in non-emergency situations in all 2024. Health data will only collected from patient's medical records.
Interventions
None listed
Sponsors
University Hospital, Clermont-Ferrand
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult man or woman * Emergency and non-emergency intubated patient in 2024 * Patient hospitalized in intensive care following intubation in 2024
Exclusion criteria
* Patient under guardianship, curatorship or safeguard of justice * Pregnant woman * Refusal to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pneumonia rate in 48 hours after the start of orotracheal intubation. | Hour 48 | Rate of pneumonia occuring within 48 hours of the start of orotracheal intubation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pneumonia rate occuring 48 hours after the start of orotracheal intubation. | 3 months | Rate of pneumonia occuring more than 48 hours after the start of orotracheal intubation. |
| Duration of mechanical ventilation | Up to the end of mechanical ventilation (assessed up to 1 month) | Duration of mechanical ventilation |
| Duration of stay in intensive care | Up to intensive care discharge (assessed up to 1 month) | Duration of stay in intensive care |
| Duration of hospital stay | Up to hospital discharge (assessed up to 3 months) | Duration of hospital stay |
| Mortality rate | Inclusion + 1 year | Mortality rate |
| Type of bacteria responsible for pneumonia | The day of the diagnosis of pneumonia (assessed up to 1 month) | The bacterial species responsible for pneumonia will be identified using biological samples (blood, urine, bronchial secretions) taken from patients in both groups. The identification of bacterial species will be carried out in the laboratory. |
| Type of antibiotic administered for pneumonia | Up to the last day of antibiotic treatment (assessed up to 3 months) | Type of antibiotic administered for pneumonia in each group |
| Antibiotic doses administered for pneumonia | Up to the last day of antibiotic treatment (assessed up to 3 months) | Comparison of antibiotic doses in g or mg administered in each group |
| Duration of antibiotic treament for pneumonia | Up to the last day of antibiotic treatment (assessed up to 3 months) | Duration of antibiotic treament for pneumonia in each group |
Countries
France
Contacts
CONTACTLise Laclautre
PRINCIPAL_INVESTIGATORJean-Baptiste BOUILLON-MINOIS
University Hospital, Clermont-Ferrand
Outcome results
None listed